泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300813 泰林生物

交易中 04-30 14:54:30

{"stockData":{"symbol":"300813","market":"SZ","secType":"STK","nameCN":"泰林生物","latestPrice":25.56,"timestamp":1777532070000,"preClose":25.43,"halted":0,"volume":1901830,"delay":0,"changeRate":0.0051,"floatShares":76051100,"shares":121000000,"eps":0.1469,"marketStatus":"交易中","change":0.13,"latestTime":"04-30 14:54:30","open":25.43,"high":26,"low":25.36,"amount":48757400,"amplitude":0.0252,"askPrice":25.58,"askSize":179,"bidPrice":25.56,"bidSize":47,"shortable":0,"etf":0,"ttmEps":0.1469,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777532400000},"marketStatusCode":2,"adr":0,"adjPreClose":25.43,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":27.97,"lowLimit":22.89,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":121199219,"isCdr":false,"pbRate":3.83,"roa":"--","peRate":173.995916,"roe":"0.6%","epsLYR":0.14,"committee":-0.311653,"marketValue":3098000000,"turnoverRate":0.025,"status":0,"floatMarketCap":1944000000},"requestUrl":"/m/hq/s/300813","defaultTab":"news","newsList":[{"id":"2631457510","title":"股市必读：泰林生物一季报 - 第一季度单季净利润同比增长37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631457510","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631457510?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:04","pubTimestamp":1777507458,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年3月31日，泰林生物股东户数达1.55万户，较2月28日增长42.43%。来自业绩披露要点：泰林生物2026年一季度归母净利润同比增长37.19%，达484.03万元。户均持股数量由上期的1.11万股减少至7806.0股，户均持股市值为22.61万元。财务报告泰林生物2026年一季报显示，一季度公司主营收入7006.35万元，同比上升4.67%；归母净利润484.03万元，同比上升37.19%；扣非净利润420.55万元，同比上升19.43%；负债率14.83%，投资收益-0.32万元，财务费用-71.51万元，毛利率50.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260430/32191134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631591311","title":"泰林生物(300813)3月31日股东户数1.55万户，较上期增加42.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631591311","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631591311?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:05","pubTimestamp":1777457146,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰林生物披露，截至2026年3月31日公司股东户数为1.55万户，较2月28日增加4625.0户，增幅为42.43%。在专用设备行业个股中，泰林生物股东户数低于行业平均水平，截至3月31日，专用设备行业平均股东户数为2.92万户。从股价来看，2026年2月28日至2026年3月31日，泰林生物区间涨幅为11.17%，在此期间股东户数增加4625.0户，增幅为42.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900057084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631562769","title":"泰林生物(300813.SZ)发布一季度业绩，归母净利润484.03万元，增长37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631562769","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631562769?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:04","pubTimestamp":1777449893,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰林生物(300813.SZ)发布2026年第一季度报告，该公司营业收入为7006.35万元，同比增长4.67%。归属于上市公司股东的净利润为484.03万元，同比增长37.19%。归属于上市公司股东的扣除非经常性损益的净利润为420.55万元，同比增长19.43%。基本每股收益为0.04元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626926523","title":"股市必读：泰林生物（300813）4月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2626926523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626926523?lang=zh_cn&edition=full","pubTime":"2026-04-09 00:58","pubTimestamp":1775667493,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，泰林生物报收于28.1元，上涨3.77%，换手率6.66%，成交量5.06万手，成交额1.42亿元。当日关注点来自交易信息汇总：4月8日主力资金净流出1362.4万元，散户资金净流入1895.03万元。来自机构调研要点：公司持续加强研发投入，巩固核心技术壁垒，并积极推进海外市场拓展，取得较快销售增长。能否详细说明答：您好，公司今年一季报的具体经营情况，请参阅公司将于 4月 28 日披露的一季度定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900000927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622806583","title":"泰林生物（300813）2025年年报简析：净利润同比增长26.32%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2622806583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622806583?lang=zh_cn&edition=full","pubTime":"2026-03-28 06:16","pubTimestamp":1774649799,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泰林生物发布2025年年报。截至本报告期末，公司营业总收入3.4亿元，同比下降2.71%，归母净利润1648.54万元，同比上升26.32%。按单季度数据看，第四季度营业总收入1.26亿元，同比上升18.6%，第四季度归母净利润176.22万元，同比上升1.51%。本报告期泰林生物盈利能力上升，毛利率同比增幅4.42%，净利率同比增幅36.61%。投资活动产生的现金流量净额变动幅度为105.67%,原因:本报告期内定期存款及理财本金到期增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800010775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622984516","title":"泰林生物拟发可转债 A股累募4.5亿元1年前被监管警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2622984516","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622984516?lang=zh_cn&edition=full","pubTime":"2026-03-27 15:28","pubTimestamp":1774596484,"startTime":"0","endTime":"0","summary":"中国经济网北京3月27日讯 泰林生物 昨晚披露向不特定对象发行可转换公司债券预案称，公司本次向不特定对象发行可转换公司债券募集资金不超过人民币23,000.00万元(含本数)，扣除发行费用后将用于以下项目：高性能过滤器及配套功能膜产业化项目、补充流动资金。该可转换公司债券及未来经本次可转换公司债券转换的公司A股股票将在深圳证券交易所创业板上市。本次发行的可转换公司债券的期限为自发行之日起6年。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/27/20260327152393.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/27/20260327152393.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260327/32104210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","159982","399300","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622858784","title":"泰林生物(300813)2月28日股东户数1.09万户，较上期增加9.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622858784","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622858784?lang=zh_cn&edition=full","pubTime":"2026-03-26 17:15","pubTimestamp":1774516559,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰林生物披露，截至2026年2月28日公司股东户数为1.09万户，较12月31日增加949.0户，增幅为9.54%。在专用设备行业个股中，泰林生物股东户数低于行业平均水平，截至2月28日，专用设备行业平均股东户数为2.86万户。从股价来看，2025年12月31日至2026年2月28日，泰林生物区间涨幅为6.06%，在此期间股东户数增加949.0户，增幅为9.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600030913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622326858","title":"泰林生物(300813.SZ)发布2025年度业绩，归母净利润1648.54万元，增长26.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622326858","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622326858?lang=zh_cn&edition=full","pubTime":"2026-03-26 17:08","pubTimestamp":1774516108,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰林生物(300813.SZ)发布2025年年度报告，该公司营业收入为3.4亿元，同比减少2.71%。归属于上市公司股东的净利润为1648.54万元，同比增长26.32%。归属于上市公司股东的扣除非经常性损益的净利润为1052.76万元，同比增长57.60%。基本每股收益为0.14元。此外，拟向全体股东每10股派发现金红利0.3元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588352110","title":"泰林生物：三季度净利润下降约355万","url":"https://stock-news.laohu8.com/highlight/detail?id=2588352110","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588352110?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:00","pubTimestamp":1764666042,"startTime":"0","endTime":"0","summary":"证券之星消息，泰林生物12月02日在投资者关系平台上答复投资者关心的问题。泰林生物回复：您好，公司2025年第三季度净利润同比下降了约355万，主要原因是第三季度公司营业收入有所下降，尽管整体毛利率同比有所提升，但不足以抵销收入下降的影响，导致销售毛利有所下降；公司于2025年二季度推出了员工持股计划，相应地三季度同比会增加股份支付费用；其他项目的综合影响，包括费用、其他收益和减值损失计提等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200024450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586223668","title":"泰林生物：公司具体股东人数信息请参阅公司披露的定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2586223668","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586223668?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:08","pubTimestamp":1764245280,"startTime":"0","endTime":"0","summary":"证券日报网讯11月27日，泰林生物在互动平台回答投资者提问时表示，公司具体股东人数信息请参阅公司披露的定期报告。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvy9112514.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvy9112514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518717446","title":"泰林生物最新公告：拟2000万元-4000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2518717446","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518717446?lang=zh_cn&edition=full","pubTime":"2025-03-11 19:20","pubTimestamp":1741692018,"startTime":"0","endTime":"0","summary":"泰林生物(300813.SZ)公告称，公司于2025年3月11日召开董事会和监事会，审议通过回购公司股份方案。公司拟使用自有资金和/或自筹资金以集中竞价交易方式回购部分社会公众股股份，用于员工持股计划。回购价格不超过人民币27.56元/股，回购资金总额不低于人民币2,000万元且不超过人民币4,000万元。回购实施期限为自董事会审议通过回购方案之日起12个月内。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100035437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518717834","title":"泰林生物(300813.SZ)拟推2025年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2518717834","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518717834?lang=zh_cn&edition=full","pubTime":"2025-03-11 19:19","pubTimestamp":1741691978,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰林生物 发布2025年员工持股计划(草案)，持股计划的股票来源为公司回购专用证券账户所持有的公司A股普通股股票。此次员工持股计划的存续期为48个月，自公司公告最后一笔标的股票过户至本员工持股计划名下之日起算。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514217358","title":"重大事项未及时披露！泰林生物及相关责任人被出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2514217358","media":"新浪证券","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514217358?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:07","pubTimestamp":1740643620,"startTime":"0","endTime":"0","summary":"　　2月27日浙江证监局发布公告，对浙江泰林生物技术股份有限公司及其时任董事长叶大林、财务总监兼董事会秘书叶星月采取出具警示函的监督管理措施，并记入证券期货市场诚信档案。　　公告显示，泰林生物存在部分募投项目产能不足、自建项目用地变更、对合资公司暂停投资等重大事项未及时披露的情况。泰林生物需在收到决定书之日起10个工作日内向浙江证监局提交书面整改报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2025-02-27/doc-inemxeui7957168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514062559","title":"泰林生物因未及时披露公司重大事件等违规行为被证监会出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2514062559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514062559?lang=zh_cn&edition=full","pubTime":"2025-02-25 19:00","pubTimestamp":1740481235,"startTime":"0","endTime":"0","summary":"证券之星消息，2月25日泰林生物公开信息显示，浙江泰林生物技术股份有限公司，董事长叶大林、叶星月因未及时披露公司重大事件,未依法履行其他职责被中国证券监督管理委员会浙江监管局出具警示函。详细违规行为如下：我局在现场检查中发现浙江泰林生物技术股份有限公司(以下简称公司)存在部分募投项目产能不足、自建项目用地变更、对合资公司暂停投资的情况未及时披露等问题。处罚决定如下：采取出具警示函的监督管理措施,并记入证券期货市场诚信档案以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500034647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514068598","title":"泰林生物最新公告：因部分募投项目产能不足等问题收到警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2514068598","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514068598?lang=zh_cn&edition=full","pubTime":"2025-02-25 17:01","pubTimestamp":1740474084,"startTime":"0","endTime":"0","summary":"泰林生物公告称，公司及相关人员收到浙江证监局出具的警示函，因公司存在部分募投项目产能不足、自建项目用地变更、对合资公司暂停投资的情况未及时披露等问题。公司时任董事长叶大林、财务总监兼董事会秘书叶星月也违反了相关规定。公司及相关人员将吸取教训，加强法律法规学习，提高规范运作意识，保证信息披露的真实、准确、完整、及时、公平，并在规定期限内向浙江证监局提交书面报告。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500029618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514068830","title":"泰林生物(300813.SZ)收到浙江证监局警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2514068830","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514068830?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:59","pubTimestamp":1740473976,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰林生物(300813.SZ)公告，公司近日收到浙江证监局出具的《关于对浙江泰林生物技术股份有限公司及相关人员采取出具警示函措施的决定》。决定书指出公司存在部分募投项目产能不足、自建项目用地变更、对合资公司暂停投资的情况未及时披露等问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"泰林生物(300813.SZ)收到浙江证监局警示函","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514050477","title":"【泰林生物：收到浙江证监局警示函】金融界2月25日消息，泰林生物于近日收到中国证券监督管理委员会浙江监管局出具的《关于对浙江泰林生物技术股份有限公司及相关人员采取出具警示函措施的决定》。公司存在部分募投项目产能不足、自建项目用地变更、对合资公司暂停投资情况未及时披露等问题。公司、时任董事长叶大林、财务总监兼董事会秘书叶星月分别被采取出具警示函的监督管理措施，并记入证券期货市场诚信档案。公司及相关人员高度重视问题，将按要求提交书面报告，此事项不影响公司正常经营，公司将依法依规履行信息披露义务。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514050477","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514050477?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:54","pubTimestamp":1740473692,"startTime":"0","endTime":"0","summary":"金融界2月25日消息，泰林生物于近日收到中国证券监督管理委员会浙江监管局出具的《关于对浙江泰林生物技术股份有限公司及相关人员采取出具警示函措施的决定》。公司存在部分募投项目产能不足、自建项目用地变更、对合资公司暂停投资情况未及时披露等问题。公司、时任董事长叶大林、财务总监兼董事会秘书叶星月分别被采取出具警示函的监督管理措施，并记入证券期货市场诚信档案。公司及相关人员高度重视问题，将按要求提交书面报告，此事项不影响公司正常经营，公司将依法依规履行信息披露义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25165448371538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501261273","title":"泰林生物收盘上涨2.60%，滚动市盈率222.81倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2501261273","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501261273?lang=zh_cn&edition=full","pubTime":"2025-01-07 17:56","pubTimestamp":1736243812,"startTime":"0","endTime":"0","summary":"1月7日，泰林生物今日收盘17.78元，上涨2.60%，滚动市盈率PE达到222.81倍。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均44.36倍，行业中值31.48倍，泰林生物排名第114位。股东方面，截至2024年9月30日，泰林生物股东户数11207户，较上次减少1057户，户均持股市值35.28万元，户均持股数量2.76万股。浙江泰林生物技术股份有限公司的主营业务是微生物检测系统、环境生物污染控制装备及总有机碳分析仪器等产品的研发、生产和销售。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/07175647214559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777532073376,"stockEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.1765},{"period":"3month","weight":0.0371},{"period":"6month","weight":-0.1481},{"period":"1year","weight":0.4966},{"period":"ytd","weight":0.035}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江泰林生物技术股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"15526人(较上一季度增加42.43%)","perCapita":"4898股","listingDate":"2020-01-14","address":"浙江省杭州市滨江区南环路2930号","registeredCapital":"12119万元","survey":"　　浙江泰林生物技术股份有限公司的主营业务是无菌生产与污染控制设备、微生物检测及有机物分析等产品的研发、生产和销售。公司的主要产品是集菌仪、集菌培养器、微生物检验仪、微孔滤膜、酶底物法大肠菌群检测系统、酶底物智能培养计数系统、全自动两虫检测系统、生物指示剂、生物指示剂抗力仪、质控菌株、隔离器、无菌传递舱、阻遏隔离器、多功能细胞处理工作站、蜂巢培养系统（转运车+蜂巢培养箱）、无菌分装工作站、汽化过氧化氢发生器、过氧化氢雾化消毒机、全自动菌落计数工作站、全自动无菌检查培养系统、细菌侵入测试仪、TOC分析仪、固体燃烧装置、生物降解测试系统、真空/压力衰减测试仪、顶空氧分析仪、过滤器完整性测试仪、过氧化氢气体浓度分析仪、水气体浓度分析仪、二氧化碳气体浓度传感器。","listedPrice":18.35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰林生物(300813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰林生物,300813,泰林生物股票,泰林生物股票老虎,泰林生物股票老虎国际,泰林生物行情,泰林生物股票行情,泰林生物股价,泰林生物股市,泰林生物股票价格,泰林生物股票交易,泰林生物股票购买,泰林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰林生物(300813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}